Mangione Renews Bid to Dismiss New York Murder Case

Mangione’s lawyers are again asking a New York judge to throw out the state case over the killing of UnitedHealthcare chief executive Brian Thompson. They argue that Mangione’s August guilty plea to federal stalking charges means New York cannot prosecute him separately for the same conduct under state double-jeopardy law.

The defense says the federal and state cases concern the same victim, shooting and alleged intent to kill. Mangione pleaded guilty in federal court to stalking offenses connected to Thompson’s death outside a Manhattan hotel on December 4, 2024. His state trial had been scheduled for September before it was postponed following the plea.

Manhattan prosecutors oppose dismissal. They argue that federal stalking charges and state murder and weapons offenses address different misconduct, so the state prosecution can proceed under an exception to New York’s double-jeopardy protections.

The defense disputes that distinction, arguing that stalking resulting in death can cover conduct that also amounts to intentional killing. Its filing also says the state case involves the same firearm used in the federal case.

Judge Gregory Carro plans to listen to the parties’ presentations on December 10 and will decide whether the state indictment can proceed. If it does, Mangione faces a maximum sentence of 25 years to life in the state case. He faces a potential life sentence in federal court, where he is due back on December 18.

New York Must Prove Its Case, Not Repeat a Federal Prosecution

New York should not be able to turn one alleged killing into two prosecutions, Mangione’s defense argues in its renewed motion to dismiss the state murder and weapons case. The lawyers say his guilty plea to federal stalking charges already addressed the conduct at the heart of the case: the killing of UnitedHealthcare chief executive Brian Thompson.

Mangione pleaded guilty in August to federal stalking offenses tied to Thompson’s death outside a Manhattan hotel on December 4, 2024. His attorneys argue that both cases concern the same victim, shooting and intent, and that New York’s double-jeopardy law bars a separate state trial.

Manhattan prosecutors insist the cases are different: federal stalking charges on one side, state murder and weapons charges on the other. The defense says that distinction fails when the federal stalking prosecution involved a death and the same firearm.

Judge Gregory Carro is due to hear arguments on December 10. The question is whether prosecutors can pursue the state indictment despite the federal plea; if the case proceeds, Mangione faces up to 25 years to life in state prison. He faces a potential life sentence in federal court and is due back there on December 18.

Different Charges Give New York a Case Against Mangione

A federal guilty plea should not erase New York’s separate murder case, Manhattan prosecutors argue as they oppose Mangione’s latest bid for dismissal. Their position is that stalking and murder are distinct offenses, allowing the state case to proceed under New York’s double-jeopardy rules.

Mangione’s lawyers filed their renewed motion on October 30, saying the federal and state prosecutions arise from the same victim, shooting and alleged intent to kill. Mangione pleaded guilty in August to federal stalking charges related to the killing of UnitedHealthcare chief executive Brian Thompson outside a Manhattan hotel on December 4, 2024.

The defense says New York’s case repeats the core misconduct already addressed in federal court. Prosecutors counter that the state murder and weapons charges are not the same as the federal stalking offenses. The judge must decide whether the distinction meets the state-law exception that prosecutors invoke.

Judge Gregory Carro is scheduled to hear arguments on December 10. If the state case goes forward, Mangione faces a maximum sentence of 25 years to life there; he also faces a potential life sentence in federal court and is due back there on December 18.